nodes	percent_of_prediction	percent_of_DWPC	metapath
Remoxipride—DRD3—Parkinson's disease	0.303	0.368	CbGaD
Remoxipride—DRD2—Parkinson's disease	0.209	0.255	CbGaD
Remoxipride—HTR2A—Parkinson's disease	0.162	0.197	CbGaD
Remoxipride—CYP2D6—Parkinson's disease	0.148	0.18	CbGaD
Remoxipride—DRD3—telencephalic ventricle—Parkinson's disease	0.00747	0.109	CbGeAlD
Remoxipride—HTR2A—enteric nervous system—Parkinson's disease	0.00665	0.0971	CbGeAlD
Remoxipride—HTR2A—myenteric nerve plexus—Parkinson's disease	0.00504	0.0736	CbGeAlD
Remoxipride—HTR2A—locus ceruleus—Parkinson's disease	0.00439	0.0641	CbGeAlD
Remoxipride—HTR2A—cerebellar cortex—Parkinson's disease	0.00358	0.0523	CbGeAlD
Remoxipride—HTR2A—sympathetic nervous system—Parkinson's disease	0.00347	0.0507	CbGeAlD
Remoxipride—DRD2—telencephalic ventricle—Parkinson's disease	0.00316	0.0461	CbGeAlD
Remoxipride—HTR2A—pons—Parkinson's disease	0.00253	0.0369	CbGeAlD
Remoxipride—HTR2A—autonomic nervous system—Parkinson's disease	0.00233	0.0341	CbGeAlD
Remoxipride—HTR2A—telencephalic ventricle—Parkinson's disease	0.00208	0.0304	CbGeAlD
Remoxipride—DRD2—nerve—Parkinson's disease	0.00199	0.029	CbGeAlD
Remoxipride—Alizapride—DRD2—Parkinson's disease	0.00173	0.237	CrCbGaD
Remoxipride—HTR2A—peripheral nervous system—Parkinson's disease	0.00168	0.0246	CbGeAlD
Remoxipride—DRD2—hindbrain—Parkinson's disease	0.00149	0.0218	CbGeAlD
Remoxipride—HTR2A—nerve—Parkinson's disease	0.00131	0.0192	CbGeAlD
Remoxipride—Amisulpride—HTR7—Parkinson's disease	0.00124	0.17	CrCbGaD
Remoxipride—Amisulpride—DRD3—Parkinson's disease	0.00117	0.16	CrCbGaD
Remoxipride—DRD4—brain—Parkinson's disease	0.00115	0.0168	CbGeAlD
Remoxipride—DRD3—head—Parkinson's disease	0.00112	0.0163	CbGeAlD
Remoxipride—DRD3—nervous system—Parkinson's disease	0.00106	0.0154	CbGeAlD
Remoxipride—Sulpiride—DRD3—Parkinson's disease	0.00102	0.14	CrCbGaD
Remoxipride—DRD3—central nervous system—Parkinson's disease	0.00102	0.0149	CbGeAlD
Remoxipride—HTR2A—hindbrain—Parkinson's disease	0.000983	0.0143	CbGeAlD
Remoxipride—CYP2D6—hindbrain—Parkinson's disease	0.000896	0.0131	CbGeAlD
Remoxipride—DRD2—brainstem—Parkinson's disease	0.000855	0.0125	CbGeAlD
Remoxipride—DRD2—forebrain—Parkinson's disease	0.000825	0.012	CbGeAlD
Remoxipride—Amisulpride—DRD2—Parkinson's disease	0.000809	0.111	CrCbGaD
Remoxipride—DRD3—brain—Parkinson's disease	0.000809	0.0118	CbGeAlD
Remoxipride—SIGMAR1—medulla oblongata—Parkinson's disease	0.000738	0.0108	CbGeAlD
Remoxipride—Sulpiride—DRD2—Parkinson's disease	0.000707	0.0968	CrCbGaD
Remoxipride—SIGMAR1—midbrain—Parkinson's disease	0.000674	0.00984	CbGeAlD
Remoxipride—SIGMAR1—spinal cord—Parkinson's disease	0.000658	0.0096	CbGeAlD
Remoxipride—Amisulpride—HTR2A—Parkinson's disease	0.000625	0.0856	CrCbGaD
Remoxipride—HTR2A—embryo—Parkinson's disease	0.000615	0.00897	CbGeAlD
Remoxipride—HTR2A—brainstem—Parkinson's disease	0.000564	0.00822	CbGeAlD
Remoxipride—DRD2—midbrain—Parkinson's disease	0.000545	0.00795	CbGeAlD
Remoxipride—HTR2A—forebrain—Parkinson's disease	0.000544	0.00794	CbGeAlD
Remoxipride—SIGMAR1—cerebellum—Parkinson's disease	0.000522	0.00761	CbGeAlD
Remoxipride—CYP2D6—brainstem—Parkinson's disease	0.000513	0.00749	CbGeAlD
Remoxipride—CYP2D6—forebrain—Parkinson's disease	0.000496	0.00723	CbGeAlD
Remoxipride—DRD2—head—Parkinson's disease	0.000472	0.00689	CbGeAlD
Remoxipride—HTR2A—cardiovascular system—Parkinson's disease	0.00046	0.00671	CbGeAlD
Remoxipride—DRD2—nervous system—Parkinson's disease	0.000448	0.00653	CbGeAlD
Remoxipride—DRD2—central nervous system—Parkinson's disease	0.000431	0.00629	CbGeAlD
Remoxipride—SIGMAR1—brain—Parkinson's disease	0.000424	0.00618	CbGeAlD
Remoxipride—DRD2—cerebellum—Parkinson's disease	0.000421	0.00615	CbGeAlD
Remoxipride—HTR2A—medulla oblongata—Parkinson's disease	0.000393	0.00573	CbGeAlD
Remoxipride—HTR2A—midbrain—Parkinson's disease	0.000359	0.00524	CbGeAlD
Remoxipride—HTR2A—spinal cord—Parkinson's disease	0.00035	0.00511	CbGeAlD
Remoxipride—DRD2—brain—Parkinson's disease	0.000342	0.00499	CbGeAlD
Remoxipride—HTR2A—head—Parkinson's disease	0.000311	0.00454	CbGeAlD
Remoxipride—HTR2A—nervous system—Parkinson's disease	0.000295	0.00431	CbGeAlD
Remoxipride—HTR2A—central nervous system—Parkinson's disease	0.000284	0.00415	CbGeAlD
Remoxipride—CYP2D6—head—Parkinson's disease	0.000284	0.00414	CbGeAlD
Remoxipride—HTR2A—cerebellum—Parkinson's disease	0.000278	0.00405	CbGeAlD
Remoxipride—CYP2D6—nervous system—Parkinson's disease	0.000269	0.00393	CbGeAlD
Remoxipride—CYP2D6—central nervous system—Parkinson's disease	0.000259	0.00378	CbGeAlD
Remoxipride—CYP2D6—cerebellum—Parkinson's disease	0.000253	0.00369	CbGeAlD
Remoxipride—HTR2A—brain—Parkinson's disease	0.000226	0.00329	CbGeAlD
Remoxipride—CYP2D6—brain—Parkinson's disease	0.000206	0.003	CbGeAlD
Remoxipride—DRD4—Signaling Pathways—GRK5—Parkinson's disease	4.89e-05	0.000479	CbGpPWpGaD
Remoxipride—HTR2A—GPCR ligand binding—HTR7—Parkinson's disease	4.86e-05	0.000477	CbGpPWpGaD
Remoxipride—HTR2A—GPCR ligand binding—DRD2—Parkinson's disease	4.86e-05	0.000477	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—HTR1A—Parkinson's disease	4.86e-05	0.000476	CbGpPWpGaD
Remoxipride—CYP2D6—Biological oxidations—GSTM1—Parkinson's disease	4.84e-05	0.000474	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—PDYN—Parkinson's disease	4.82e-05	0.000472	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—TAC1—Parkinson's disease	4.79e-05	0.000469	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—PENK—Parkinson's disease	4.78e-05	0.000469	CbGpPWpGaD
Remoxipride—CYP2D6—Metapathway biotransformation—GSTM1—Parkinson's disease	4.77e-05	0.000468	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—PDYN—Parkinson's disease	4.74e-05	0.000465	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—PENK—Parkinson's disease	4.7e-05	0.000461	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—DRD1—Parkinson's disease	4.69e-05	0.00046	CbGpPWpGaD
Remoxipride—HTR2A—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	4.63e-05	0.000454	CbGpPWpGaD
Remoxipride—HTR2A—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	4.62e-05	0.000453	CbGpPWpGaD
Remoxipride—DRD3—Circadian rythm related genes—MAPK8—Parkinson's disease	4.6e-05	0.000451	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—RIT2—Parkinson's disease	4.58e-05	0.000449	CbGpPWpGaD
Remoxipride—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	4.55e-05	0.000446	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—DRD3—Parkinson's disease	4.55e-05	0.000446	CbGpPWpGaD
Remoxipride—DRD3—GPCR ligand binding—HTR2A—Parkinson's disease	4.53e-05	0.000444	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—ADORA2A—Parkinson's disease	4.52e-05	0.000443	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—GRM5—Parkinson's disease	4.48e-05	0.000439	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—HTR1A—Parkinson's disease	4.41e-05	0.000433	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—GRM5—Parkinson's disease	4.4e-05	0.000432	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—GRM4—Parkinson's disease	4.38e-05	0.00043	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—DGKQ—Parkinson's disease	4.38e-05	0.00043	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—GPR37—Parkinson's disease	4.38e-05	0.00043	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—PDYN—Parkinson's disease	4.37e-05	0.000429	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—TAC1—Parkinson's disease	4.35e-05	0.000426	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—GRK5—Parkinson's disease	4.34e-05	0.000426	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—HTR1A—Parkinson's disease	4.32e-05	0.000423	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—DGKQ—Parkinson's disease	4.31e-05	0.000423	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—GPR37—Parkinson's disease	4.31e-05	0.000423	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—PDYN—Parkinson's disease	4.3e-05	0.000422	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—DRD1—Parkinson's disease	4.26e-05	0.000418	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—TAC1—Parkinson's disease	4.25e-05	0.000417	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—ADRBK1—Parkinson's disease	4.24e-05	0.000416	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—DRD1—Parkinson's disease	4.17e-05	0.000409	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—PENK—Parkinson's disease	4.16e-05	0.000407	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—MAG—Parkinson's disease	4.16e-05	0.000407	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—DRD3—Parkinson's disease	4.13e-05	0.000405	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—DRD2—Parkinson's disease	4.11e-05	0.000403	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—HTR7—Parkinson's disease	4.11e-05	0.000403	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—GRM5—Parkinson's disease	4.07e-05	0.000399	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—PPP1R1B—Parkinson's disease	4.01e-05	0.000393	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—GRM5—Parkinson's disease	4e-05	0.000392	CbGpPWpGaD
Remoxipride—DRD2—GPCR ligand binding—EDN1—Parkinson's disease	3.96e-05	0.000388	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—PPP1R1B—Parkinson's disease	3.94e-05	0.000387	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—HTR1A—Parkinson's disease	3.92e-05	0.000384	CbGpPWpGaD
Remoxipride—HTR2A—GPCR ligand binding—EDN1—Parkinson's disease	3.89e-05	0.000382	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—GRM4—Parkinson's disease	3.89e-05	0.000382	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—TAC1—Parkinson's disease	3.86e-05	0.000379	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—ADRBK1—Parkinson's disease	3.85e-05	0.000378	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—ADORA2A—Parkinson's disease	3.81e-05	0.000373	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—PDYN—Parkinson's disease	3.8e-05	0.000373	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—DRD1—Parkinson's disease	3.79e-05	0.000371	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—ADRBK1—Parkinson's disease	3.77e-05	0.00037	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—ADORA2A—Parkinson's disease	3.75e-05	0.000367	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—HTR7—Parkinson's disease	3.73e-05	0.000366	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—DRD2—Parkinson's disease	3.73e-05	0.000366	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—MAG—Parkinson's disease	3.69e-05	0.000362	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—PENK—Parkinson's disease	3.69e-05	0.000362	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—HTR7—Parkinson's disease	3.65e-05	0.000358	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—DRD2—Parkinson's disease	3.65e-05	0.000358	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—GFAP—Parkinson's disease	3.57e-05	0.00035	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—GRM5—Parkinson's disease	3.53e-05	0.000346	CbGpPWpGaD
Remoxipride—DRD2—Circadian rythm related genes—MAPK8—Parkinson's disease	3.52e-05	0.000345	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—RIT2—Parkinson's disease	3.5e-05	0.000344	CbGpPWpGaD
Remoxipride—DRD2—GPCR ligand binding—HTR2A—Parkinson's disease	3.46e-05	0.00034	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—ADORA2A—Parkinson's disease	3.46e-05	0.000339	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—RIT2—Parkinson's disease	3.45e-05	0.000338	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—ND3—Parkinson's disease	3.43e-05	0.000336	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—MCCC1—Parkinson's disease	3.43e-05	0.000336	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—ADRBK1—Parkinson's disease	3.42e-05	0.000336	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—ADORA2A—Parkinson's disease	3.4e-05	0.000334	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—PDYN—Parkinson's disease	3.38e-05	0.000331	CbGpPWpGaD
Remoxipride—HTR2A—SIDS Susceptibility Pathways—TNF—Parkinson's disease	3.36e-05	0.000329	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—GRK5—Parkinson's disease	3.32e-05	0.000326	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—DRD2—Parkinson's disease	3.32e-05	0.000325	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—HTR7—Parkinson's disease	3.32e-05	0.000325	CbGpPWpGaD
Remoxipride—DRD4—Circadian rythm related genes—IL6—Parkinson's disease	3.31e-05	0.000324	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—HTR1A—Parkinson's disease	3.3e-05	0.000324	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—EDN1—Parkinson's disease	3.29e-05	0.000323	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—GRK5—Parkinson's disease	3.27e-05	0.00032	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—TAC1—Parkinson's disease	3.25e-05	0.000319	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—HTR1A—Parkinson's disease	3.25e-05	0.000319	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—OMD—Parkinson's disease	3.23e-05	0.000316	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—TALDO1—Parkinson's disease	3.23e-05	0.000316	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—TAC1—Parkinson's disease	3.2e-05	0.000314	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—DRD1—Parkinson's disease	3.19e-05	0.000313	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—GFAP—Parkinson's disease	3.17e-05	0.000311	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—DRD1—Parkinson's disease	3.14e-05	0.000308	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—GRM5—Parkinson's disease	3.14e-05	0.000308	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—FGF20—Parkinson's disease	3.1e-05	0.000304	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—DRD3—Parkinson's disease	3.09e-05	0.000303	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—NDUFB11—Parkinson's disease	3.06e-05	0.0003	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—DRD3—Parkinson's disease	3.04e-05	0.000298	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—ADORA2A—Parkinson's disease	3e-05	0.000295	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—HTR1A—Parkinson's disease	3e-05	0.000294	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—EDN1—Parkinson's disease	2.99e-05	0.000293	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—GRM4—Parkinson's disease	2.98e-05	0.000292	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—TAC1—Parkinson's disease	2.95e-05	0.00029	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—HTR1A—Parkinson's disease	2.95e-05	0.000289	CbGpPWpGaD
Remoxipride—DRD3—Circadian rythm related genes—IL6—Parkinson's disease	2.94e-05	0.000288	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—GRM4—Parkinson's disease	2.93e-05	0.000287	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—EDN1—Parkinson's disease	2.92e-05	0.000287	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—GCH1—Parkinson's disease	2.92e-05	0.000286	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—TAC1—Parkinson's disease	2.91e-05	0.000285	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—DRD1—Parkinson's disease	2.9e-05	0.000284	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—ADRBK1—Parkinson's disease	2.88e-05	0.000283	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—HTR2A—Parkinson's disease	2.88e-05	0.000282	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—DRD1—Parkinson's disease	2.85e-05	0.000279	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—ADRBK1—Parkinson's disease	2.84e-05	0.000278	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—PENK—Parkinson's disease	2.82e-05	0.000277	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—MAG—Parkinson's disease	2.82e-05	0.000277	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—DRD3—Parkinson's disease	2.81e-05	0.000275	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—HTR7—Parkinson's disease	2.79e-05	0.000274	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—PENK—Parkinson's disease	2.78e-05	0.000272	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—MAG—Parkinson's disease	2.78e-05	0.000272	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—INSR—Parkinson's disease	2.77e-05	0.000272	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—DRD3—Parkinson's disease	2.76e-05	0.000271	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—FGF20—Parkinson's disease	2.75e-05	0.00027	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—HTR7—Parkinson's disease	2.75e-05	0.00027	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—DRD2—Parkinson's disease	2.75e-05	0.00027	CbGpPWpGaD
Remoxipride—HTR2A—SIDS Susceptibility Pathways—IL6—Parkinson's disease	2.71e-05	0.000266	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—ADORA2A—Parkinson's disease	2.67e-05	0.000262	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—EDN1—Parkinson's disease	2.65e-05	0.00026	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—FGB—Parkinson's disease	2.62e-05	0.000257	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—ADRBK1—Parkinson's disease	2.62e-05	0.000257	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—HTR2A—Parkinson's disease	2.61e-05	0.000256	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—HTR1A—Parkinson's disease	2.61e-05	0.000256	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—GBA—Parkinson's disease	2.6e-05	0.000255	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—DBH—Parkinson's disease	2.6e-05	0.000255	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—FBP1—Parkinson's disease	2.6e-05	0.000255	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—PDYN—Parkinson's disease	2.58e-05	0.000253	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—ADRBK1—Parkinson's disease	2.58e-05	0.000253	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—TAC1—Parkinson's disease	2.57e-05	0.000252	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—HTR2A—Parkinson's disease	2.56e-05	0.000251	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—PDYN—Parkinson's disease	2.54e-05	0.000249	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—HTR7—Parkinson's disease	2.54e-05	0.000249	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—DRD1—Parkinson's disease	2.52e-05	0.000247	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—HTR7—Parkinson's disease	2.5e-05	0.000245	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—DRD2—Parkinson's disease	2.5e-05	0.000245	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—INSR—Parkinson's disease	2.46e-05	0.000241	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—DRD3—Parkinson's disease	2.44e-05	0.000239	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—GFAP—Parkinson's disease	2.43e-05	0.000238	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—GRM5—Parkinson's disease	2.4e-05	0.000235	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—GFAP—Parkinson's disease	2.39e-05	0.000234	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—GRM5—Parkinson's disease	2.36e-05	0.000232	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—FGB—Parkinson's disease	2.33e-05	0.000228	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—HTR2A—Parkinson's disease	2.32e-05	0.000228	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—HTR1A—Parkinson's disease	2.32e-05	0.000227	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—TAC1—Parkinson's disease	2.28e-05	0.000224	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—ADRBK1—Parkinson's disease	2.28e-05	0.000223	CbGpPWpGaD
Remoxipride—DRD2—Circadian rythm related genes—IL6—Parkinson's disease	2.25e-05	0.000221	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—EDN1—Parkinson's disease	2.24e-05	0.000219	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—DRD1—Parkinson's disease	2.24e-05	0.000219	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—DRD2—Parkinson's disease	2.21e-05	0.000216	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—HTR7—Parkinson's disease	2.21e-05	0.000216	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—EDN1—Parkinson's disease	2.2e-05	0.000216	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—FGF20—Parkinson's disease	2.11e-05	0.000206	CbGpPWpGaD
Remoxipride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	2.1e-05	0.000206	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—FGF20—Parkinson's disease	2.07e-05	0.000203	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—ADORA2A—Parkinson's disease	2.04e-05	0.0002	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—EDN1—Parkinson's disease	2.03e-05	0.000199	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—ADRBK1—Parkinson's disease	2.02e-05	0.000198	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—ADORA2A—Parkinson's disease	2.01e-05	0.000197	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—EDN1—Parkinson's disease	2e-05	0.000196	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—DRD2—Parkinson's disease	1.96e-05	0.000192	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—HTR7—Parkinson's disease	1.96e-05	0.000192	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—HTR2A—Parkinson's disease	1.96e-05	0.000192	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—DDC—Parkinson's disease	1.91e-05	0.000187	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—INSR—Parkinson's disease	1.88e-05	0.000185	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—INSR—Parkinson's disease	1.85e-05	0.000182	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—IGF2—Parkinson's disease	1.85e-05	0.000181	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—GSTA4—Parkinson's disease	1.8e-05	0.000177	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—IGF1R—Parkinson's disease	1.79e-05	0.000175	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—FGB—Parkinson's disease	1.78e-05	0.000175	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—HTR2A—Parkinson's disease	1.78e-05	0.000174	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—HTR1A—Parkinson's disease	1.77e-05	0.000174	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—EDN1—Parkinson's disease	1.77e-05	0.000173	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—FGB—Parkinson's disease	1.75e-05	0.000172	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—TAC1—Parkinson's disease	1.74e-05	0.000171	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—HTR1A—Parkinson's disease	1.74e-05	0.000171	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—TAC1—Parkinson's disease	1.72e-05	0.000168	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—DRD1—Parkinson's disease	1.71e-05	0.000168	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—DRD1—Parkinson's disease	1.68e-05	0.000165	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—DRD3—Parkinson's disease	1.66e-05	0.000163	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—IGF2—Parkinson's disease	1.64e-05	0.000161	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—DRD3—Parkinson's disease	1.63e-05	0.00016	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	1.62e-05	0.000159	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—NGF—Parkinson's disease	1.62e-05	0.000159	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—MAOB—Parkinson's disease	1.61e-05	0.000157	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—IGF1R—Parkinson's disease	1.59e-05	0.000156	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—EDN1—Parkinson's disease	1.57e-05	0.000154	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—ADRBK1—Parkinson's disease	1.55e-05	0.000152	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—HTR2A—Parkinson's disease	1.54e-05	0.000151	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—ADRBK1—Parkinson's disease	1.52e-05	0.000149	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—HTR7—Parkinson's disease	1.5e-05	0.000147	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—DRD2—Parkinson's disease	1.47e-05	0.000145	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—HTR7—Parkinson's disease	1.47e-05	0.000145	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—NGF—Parkinson's disease	1.44e-05	0.000141	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—APOE—Parkinson's disease	1.44e-05	0.000141	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—HTR2A—Parkinson's disease	1.37e-05	0.000135	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—APOE—Parkinson's disease	1.28e-05	0.000125	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—IGF2—Parkinson's disease	1.26e-05	0.000123	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—IGF2—Parkinson's disease	1.24e-05	0.000121	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—INS—Parkinson's disease	1.23e-05	0.00012	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—IGF1R—Parkinson's disease	1.21e-05	0.000119	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—EDN1—Parkinson's disease	1.2e-05	0.000118	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—IGF1R—Parkinson's disease	1.19e-05	0.000117	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—EDN1—Parkinson's disease	1.18e-05	0.000116	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—CTGF—Parkinson's disease	1.17e-05	0.000115	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—NGF—Parkinson's disease	1.1e-05	0.000108	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	1.09e-05	0.000107	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—INS—Parkinson's disease	1.09e-05	0.000107	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—NGF—Parkinson's disease	1.08e-05	0.000106	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—NQO1—Parkinson's disease	1.08e-05	0.000106	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—TH—Parkinson's disease	1.06e-05	0.000104	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—HTR2A—Parkinson's disease	1.05e-05	0.000103	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—CYCS—Parkinson's disease	1.02e-05	0.0001	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—APOE—Parkinson's disease	9.76e-06	9.57e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—APOE—Parkinson's disease	9.6e-06	9.42e-05	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—CASP3—Parkinson's disease	9.13e-06	8.95e-05	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—IL6—Parkinson's disease	9.07e-06	8.9e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—COMT—Parkinson's disease	9.05e-06	8.87e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—GSTP1—Parkinson's disease	9e-06	8.83e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—MAOA—Parkinson's disease	8.98e-06	8.81e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—HMOX1—Parkinson's disease	8.88e-06	8.71e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—ABCB1—Parkinson's disease	8.52e-06	8.36e-05	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—MAPK8—Parkinson's disease	8.39e-06	8.23e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—INS—Parkinson's disease	8.34e-06	8.17e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—GSTM1—Parkinson's disease	8.27e-06	8.11e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—INS—Parkinson's disease	8.2e-06	8.04e-05	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—CASP3—Parkinson's disease	8.11e-06	7.95e-05	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—IL6—Parkinson's disease	8.06e-06	7.9e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—GPX1—Parkinson's disease	7.92e-06	7.77e-05	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—MAPK8—Parkinson's disease	7.46e-06	7.31e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—MTHFR—Parkinson's disease	7.31e-06	7.17e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—APOE—Parkinson's disease	6.81e-06	6.68e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CASP3—Parkinson's disease	6.21e-06	6.09e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—IL6—Parkinson's disease	6.17e-06	6.05e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CASP3—Parkinson's disease	6.11e-06	5.99e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—IL6—Parkinson's disease	6.07e-06	5.95e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—INS—Parkinson's disease	5.82e-06	5.7e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—MAPK8—Parkinson's disease	5.7e-06	5.59e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—MAPK8—Parkinson's disease	5.61e-06	5.5e-05	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—IL6—Parkinson's disease	5.36e-06	5.26e-05	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—IL6—Parkinson's disease	4.76e-06	4.67e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—IL6—Parkinson's disease	3.64e-06	3.57e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—IL6—Parkinson's disease	3.58e-06	3.51e-05	CbGpPWpGaD
